[Association of chronic neutrophilic leukemia and myeloma with fibrillar inclusions in granulocytes]. 1995

H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
Department of Internal Medicine, Showa University, Fujigaoka Hospital.

A 57 year-old-female was incidentally found to have leukocytosis in September 1988. Physical examination revealed anemia and marked hepatosplenomegaly. Her WBC count was 33,400/microliters with 95% mature neutrophils showing toxic granules. Her neutrophil alkaline phosphatase score was 482, and serum VB12 14,600 pg/ml. Serum immunoglobulin concentrations were 582 mg/dl for IgG, 3,628 mg/dl for IgA and 48 mg/dl for IgM. IgA was determined as monoclonal origin of lambda type. Bone marrow aspiration revealed a hypercellular marrow with active granulocytopoiesis and increased plasma cells. Cytogenetic study revealed normal karyotype. The bcr rearrangement was negative for bone marrow cells. An electronmicroscopy demonstrated fibrillar inclusions in granulocytes. We diagnosed this case as a chronic neutrophilic leukemia (CNL) associated with multiple myeloma. She was treated with a course of low dose busulfan without beneficial response. She was admitted for development of huge subcutaneous hematoma of left waist in October 1990. Laboratory findings were: Hb 7.0 g/dl, WBC 55, 300/microliters, Platelets 3.3 x 10(4)/microliters, and IgA 6,607 mg/dl. She required frequent transfusions. She died of pneumonia in July 1991. The peculiar fibrillar inclusions with CNL has not been reported so far. The origin and significance of such structure remains uncertain.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D002479 Inclusion Bodies A generic term for any circumscribed mass of foreign (e.g., lead or viruses) or metabolically inactive materials (e.g., ceroid or MALLORY BODIES), within the cytoplasm or nucleus of a cell. Inclusion bodies are in cells infected with certain filtrable viruses, observed especially in nerve, epithelial, or endothelial cells. (Stedman, 25th ed) Cellular Inclusions,Cytoplasmic Inclusions,Bodies, Inclusion,Body, Inclusion,Cellular Inclusion,Cytoplasmic Inclusion,Inclusion Body,Inclusion, Cellular,Inclusion, Cytoplasmic,Inclusions, Cellular,Inclusions, Cytoplasmic
D005260 Female Females
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015467 Leukemia, Neutrophilic, Chronic A rare myeloproliferative disorder that is characterized by a sustained, mature neutrophilic leukocytosis. No monocytosis, EOSINOPHILIA, or basophilia is present, nor is there a PHILADELPHIA CHROMOSOME or bcr-abl fusion gene (GENES, ABL). Neutrophilic Leukemia, Chronic,Chronic Neutrophilic Leukemia,Chronic Neutrophilic Leukemias,Leukemia, Chronic Neutrophilic,Leukemias, Chronic Neutrophilic,Neutrophilic Leukemias, Chronic

Related Publications

H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
March 2002, Leukemia & lymphoma,
H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
July 1990, Cancer,
H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
October 1992, Sangre,
H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
January 1994, Acta haematologica,
H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
May 2021, EJHaem,
H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
February 1984, Tumori,
H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
August 1993, Journal of the American Academy of Dermatology,
H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
March 2004, European journal of haematology,
H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
November 2023, Annals of hematology,
H Mori, and N Takahashi, and J Tada, and T Maeda, and T Higuchi, and T Shimizu, and H Harada, and Y Miyoshi, and S Okada, and H Niikura
August 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Copied contents to your clipboard!